Table 1 Patients characteristics
Demography | |
Median age (years) (range) | 60 (50–72) |
Female | 16 (64%) |
Disease stage | |
I | 2 (8%) |
III | 1 (4%) |
III | 1 (4%) |
IV | 21 (84%) |
Tumor sample | |
Surgery | 17 (68%) |
Core Needle Biopsy | 8 (32%) |
Tumor sample source | |
Primary Tumor | 8 (32%) |
Colon | 5 (20%) |
Rectum | 3 (12%) |
Metastasis | 17 (68%) |
Liver | 15 (60%) |
Peritoneum | 1 (4%) |
Ovary | 1 (4%) |
Prior treatment lines | |
0 | 6 (24%) |
1 | 8 (32%) |
2 | 7 (28%) |
3 + | 4 (16%) |
Prior drug regimens received | |
FOLFOX | 12 (48%) |
FOLFIRI | 8 (32%) |
FOLFIRINOX | 8 (32%) |
Anti-EGFR | 11 (44%) |
Anti-VEGFR | 9 (36%) |
Regorafenib | 1 (4%) |
Trifluridin/Tipiracil | 2 (8%) |